SAGE Journals
Browse
Supplementary_File_S3.pdf (33.06 kB)

Supplementary_File_S3 – Supplemental material for Reasons to switch: a noninterventional study evaluating immunotherapy switches in a large German multicentre cohort of patients with relapsing-remitting multiple sclerosis

Download (33.06 kB)
journal contribution
posted on 2019-12-20, 13:07 authored by Mathias Mäurer, Klaus Tiel-Wilck, Eckard Oehm, Nils Richter, Michael Springer, Patrick Oschmann, Arndt Manzel, Stefanie Hieke-Schulz, Vera Zingler, Julia A. Kandenwein, Tjalf Ziemssen, Ralf A. Linker

Supplemental material, Supplementary_File_S3 for Reasons to switch: a noninterventional study evaluating immunotherapy switches in a large German multicentre cohort of patients with relapsing-remitting multiple sclerosis by Mathias Mäurer, Klaus Tiel-Wilck, Eckard Oehm, Nils Richter, Michael Springer, Patrick Oschmann, Arndt Manzel, Stefanie Hieke-Schulz, Vera Zingler, Julia A. Kandenwein, Tjalf Ziemssen and Ralf A. Linker in Therapeutic Advances in Neurological Disorders

Funding

Roche Pharma AG, Grenzach-Wyhlen

History